Shares of Kodiak Sciences KOD rallied 29.6% on Monday after an eminent financial services company, Jefferies, upgraded KOD to ...

The EMA has validated Chiesi Global Rare Diseases and Protalix’s submission to update the dosing regimen of pegunigalsidase alfa.

The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...

Real-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) ...